scholarly journals An amylin and calcitonin receptor agonist modulates alcohol behaviors by acting on reward-related areas in the brain

2020 ◽  
pp. 101969
Author(s):  
Aimilia Lydia Kalafateli ◽  
Tugce Munise Satir ◽  
Daniel Vallöf ◽  
Henrik Zetterberg ◽  
Elisabet Jerlhag
2014 ◽  
Vol 307 (1) ◽  
pp. E24-E33 ◽  
Author(s):  
Kim V. Andreassen ◽  
Michael Feigh ◽  
Sara T. Hjuler ◽  
Sofie Gydesen ◽  
Jan Erik Henriksen ◽  
...  

The present study investigated a novel oral dual amylin and calcitonin receptor agonist (DACRA), KBP-042, in head-to-head comparison with salmon calcitonin (sCT) with regard to in vitro receptor pharmacology, ex vivo pancreatic islet studies, and in vivo proof of concept studies in diet-induced obese (DIO) and Zucker diabetic fatty (ZDF) rats. In vitro, KBP-042 demonstrated superior binding affinity and activation of amylin and calcitonin receptors, and ex vivo, KBP-042 exerted inhibitory action on stimulated insulin and glucagon release from isolated islets. In vivo, KBP-042 induced a superior and pronounced reduction in food intake in conjunction with a sustained pair-fed corrected weight loss in DIO rats. Concomitantly, KBP-042 improved glucose homeostasis and reduced hyperinsulinemia and hyperleptinemia in conjunction with enhanced insulin sensitivity. In ZDF rats, KBP-042 induced a superior attenuation of diabetic hyperglycemia and alleviated impaired glucose and insulin tolerance. Concomitantly, KBP-042 preserved insulinotropic and induced glucagonostatic action, ultimately preserving pancreatic insulin and glucagon content. In conclusion, oral KBP-042 is a novel DACRA, which exerts antiobesity and antidiabetic efficacy by dual modulation of insulin sensitivity and directly decelerating stress on the pancreatic α- and β-cells. These results could provide the basis for oral KBP-042 as a novel therapeutic agent in type 2 diabetes.


1997 ◽  
Vol 17 (9) ◽  
pp. 992-1003 ◽  
Author(s):  
Andrea Fergus ◽  
Kevin S. Lee

The role of GABA in regulating cerebral microvessels was examined in the parenchyma of the hippocampus and the surface of the neocortex. Microvessels were monitored in in vitro slices using computer-assisted videomicroscopy, and synaptically evoked field responses were simultaneously recorded. γ-Aminobutyric acid (GABA) and the GABAA receptor agonist, muscimol, elicited vasodilation in hippocampal microvessels, whereas the GABAB receptor agonist, baclofen, elicited constriction. The muscimol-induced dilation persisted in the presence of the nitric oxide synthase inhibitor, N-nitro-l-arginine, indicating that this response is not mediated by nitric oxide. Inhibition of neuronal discharge activity with tetrodotoxin did not alter this dilation, but it fully blocked the constrictor response to baclofen. These data suggest that GABAB-mediated, but not GABAA-mediated, responses are dependent on action potential generation. The GABAA receptor antagonists, bicuculline and picrotoxin, elicited constriction, suggesting a tonic dilatory influence by endogenous GABA. Bicuculline-induced constriction was not attenuated by tetrodotoxin. In contrast, these vessels were unresponsive to the GABAB receptor antagonist, 2-hydroxysaclofen. Hippocampal microvessels dilated in response to moderate hypoxia, and this response persisted in the presence of bicuculline, indicating that the hypoxia-induced dilation is not mediated by an action at GABAA receptors. In arterioles located on the surface of the neocortex (i.e., not embedded in the parenchyma of the brain), muscimol elicited vasodilation, whereas bicuculline was ineffective. These results suggest that although these vessels are responsive to GABA, the local concentration of endogenous GABA is insufficient to elicit a tonic effect at rest. These findings raise the possibility that GABA plays a role in local neurovascular signaling in the parenchyma of the brain.


2003 ◽  
Vol 20 (2) ◽  
pp. 177-188 ◽  
Author(s):  
SHIH-FANG FAN ◽  
STEPHEN YAZULLA

Endogenous cannabinoids modulate neurotransmitter action and release in the brain. The effects are exerted on membrane permeability to Ca2+ and K+via protein kinase A (PKA). Cannabinoid CB1 receptors are present at the synaptic terminals of cones in goldfish retina. We investigated the effects of CB1 receptor agonist WIN 55212-2 on voltage-gated currents of goldfish cones. Whole-cell currents were recorded with conventional-patch-clamp methods in goldfish retinal slices. Depolarizing pulses elicited inward ICa and Ioutward that contained several components: IK, IA, and ICl. WIN 55212-2 (<1 μM) enhanced IK, ICl, and ICa, while at >1 μM, IK, ICl, and ICa were suppressed. The voltage-activation ranges of these currents were not affected. All effects of WIN 55212-2 were blocked by the CB1 receptor antagonist SR 141716A as well as the PKA inhibitor Wiptide. The enhancing effect of WIN 55212-2 was blocked selectively by 0.5 nM cholera toxin and the suppressive effect was blocked by pertussis toxin. The results obtained from long and short single cones and double cones were basically the same.


2017 ◽  
Vol 106 ◽  
pp. 214-221 ◽  
Author(s):  
Mirko Santello ◽  
Alberto Bisco ◽  
Natalie Elisabeth Nevian ◽  
Enza Lacivita ◽  
Marcello Leopoldo ◽  
...  

1997 ◽  
Vol 73 ◽  
pp. 88
Author(s):  
Hironobu Maeda ◽  
Makoto Ukai ◽  
Masavuki Hiramatsu ◽  
Tsutomu Kameyama ◽  
Kiyoshi Matsuno

Sign in / Sign up

Export Citation Format

Share Document